The Quarter story
The two most recent quarterly results, compared side-by-side.
Sharda Cropchem shows strong capital efficiency and equity growth, though seasonal margins and non-agro demand require monitoring.
ROCE climbed from 16.0% to 30.4% from Q1 FY26 to Q1 FY27, showing highly efficient capital use.
EBIT margin eased from 17.2% to 11.2% from Q1 FY26 to Q1 FY27, reflecting seasonal volume pressure.
ROE rose from 12.8% to 24.2% from Q1 FY26 to Q1 FY27, reflecting strong returns for shareholders.
PAT margin dropped from 14.5% to 8.2% from Q1 FY26 to Q1 FY27, highlighting seasonal tax and cost impacts.
Total equity grew from ₹2,649 Cr to ₹3,245 Cr from Q1 FY26 to Q1 FY27, building a solid financial base.
Finance costs jumped from ₹0.6 Cr to ₹1.8 Cr from Q1 FY26 to Q1 FY27, signaling higher borrowing expenses.
Gross margin recovered from 35.5% to 36.7% from Q1 FY26 to Q1 FY27, confirming stable input cost management.
Non-agro revenue moved from ₹139 Cr to ₹159 Cr from Q1 FY26 to Q1 FY27, indicating volatile demand.
Working capital days improved from 100 to 88 from Q1 FY26 to Q1 FY27, speeding up cash conversion.
European non-agro sales fell from ₹22 Cr to ₹14 Cr from Q1 FY26 to Q4 FY26, showing weakening regional demand.
NSE
BSE
